Merck
Worldwide
   
En español

 

HIV Investigational Study

Welcome

Many advances have taken place since the introduction of life saving drugs to treat HIV and AIDS. Unfortunately, it is estimated that up to 78 percent of people taking these medications have developed resistance to more than one group of drugs, which highlights the need for new ways to treat the HIV virus.

Despite the availability of drugs to treat HIV and AIDS in some parts of the world, the epidemic continues. An estimated 40 million people are currently infected worldwide. AIDS is one of the largest infectious disease causes of mortality worldwide, responsible for three million deaths each year.

This website is designed to help people with limited treatment options find out if they are a potential candidate for new clinical trials with the investigational drug MK-0518, and to locate the nearest participating clinic. We deeply appreciate your interest and willingness to consider participating in these important clinical trials.

Copyright © 2005-2007 Merck & Co., Inc., All rights reserved.

BENCHMRK ExPI
More about
BENCHMRK-IT
More about
EARMRK

BENCHMRK
More about
Contact Merck Privacy Policy Terms of Use Copyright Merck & CO., Inc. (USA)